BenevolentAI
how approach compares to industry typical proportion of targets validated by lab assay potential increase in chance of a drug reaching the market industry time from target to candidate yrs potential time saved relative to industry at least yrs cost from target to potential cost bene per relative to industry saving | BenevolentAI
Company
Deck Type
Deck date
September 2022
Slide
17 of 74
Similar slides by BenevolentAI
Investor Conference
November 2022
Investor Presentation
October 2022
Related slides by other companies
Activist
October 2018
Investor Day
March 2022
SPAC
April 2021
SPAC
May 2022
Other recent decks by BenevolentAI
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io